H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 120 Citations 61,866 536 World Ranking 1586 National Ranking 146

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Cancer

His primary scientific interests are in Idiopathic pulmonary fibrosis, Internal medicine, Pulmonary fibrosis, Respiratory disease and Interstitial lung disease. His biological study spans a wide range of topics, including Lung biopsy and Intensive care medicine. The Internal medicine study combines topics in areas such as Gastroenterology and Surgery.

In his research, Combined pulmonary fibrosis and emphysema is intimately related to Cardiology, which falls under the overarching field of Pulmonary fibrosis. His studies in Respiratory disease integrate themes in fields like Radiology, Computed tomography, Lung volumes and Bronchiectasis. His work carried out in the field of Interstitial lung disease brings together such families of science as Vital capacity, Hypersensitivity pneumonitis and Immunology.

His most cited work include:

  • An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management (4402 citations)
  • American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias (3012 citations)
  • An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias (1870 citations)

What are the main themes of his work throughout his whole career to date?

Athol U. Wells mainly focuses on Internal medicine, Idiopathic pulmonary fibrosis, Interstitial lung disease, Pathology and Lung. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Cardiology. His research integrates issues of Pulmonary fibrosis, Vital capacity, Surgery and Intensive care medicine in his study of Idiopathic pulmonary fibrosis.

Athol U. Wells interconnects Disease and MEDLINE in the investigation of issues within Intensive care medicine. His research in Interstitial lung disease intersects with topics in Scleroderma, Radiology, Pulmonary function testing, Physical therapy and Cohort. His work deals with themes such as Idiopathic interstitial pneumonia and Respiratory system, which intersect with Pathology.

He most often published in these fields:

  • Internal medicine (43.58%)
  • Idiopathic pulmonary fibrosis (39.53%)
  • Interstitial lung disease (31.15%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (43.58%)
  • Idiopathic pulmonary fibrosis (39.53%)
  • Interstitial lung disease (31.15%)

In recent papers he was focusing on the following fields of study:

Athol U. Wells mainly investigates Internal medicine, Idiopathic pulmonary fibrosis, Interstitial lung disease, Lung and In patient. Many of his studies involve connections with topics such as Gastroenterology and Internal medicine. Athol U. Wells has researched Idiopathic pulmonary fibrosis in several fields, including Vital capacity, Respiratory system and Clinical trial.

Athol U. Wells combines subjects such as Intensive care medicine, Connective tissue, Pathology and MEDLINE with his study of Interstitial lung disease. The various areas that he examines in his Intensive care medicine study include Sarcoidosis and Disease. His studies deal with areas such as Natural history and Biopsy, Radiology as well as Lung.

Between 2018 and 2021, his most popular works were:

  • The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society (550 citations)
  • Nintedanib in Progressive Fibrosing Interstitial Lung Diseases (300 citations)
  • Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. (227 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Cancer

The scientist’s investigation covers issues in Idiopathic pulmonary fibrosis, Internal medicine, Interstitial lung disease, Lung and FEV1/FVC ratio. His Idiopathic pulmonary fibrosis study focuses on Usual interstitial pneumonia in particular. His Internal medicine study frequently links to related topics such as Placebo.

His work on Idiopathic interstitial pneumonia as part of general Interstitial lung disease study is frequently linked to In patient, therefore connecting diverse disciplines of science. His Lung research incorporates elements of Pathological, Disease, Pathology and Pneumonia. His FEV1/FVC ratio research incorporates themes from Lung volumes and Hazard ratio.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management

Ganesh Raghu;Harold R. Collard;Jim J. Egan;Fernando J. Martinez.
American Journal of Respiratory and Critical Care Medicine (2011)

6670 Citations

American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch.
American Journal of Respiratory and Critical Care Medicine (2002)

4192 Citations

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King.
American Journal of Respiratory and Critical Care Medicine (2013)

2410 Citations

Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Harold R. Collard;Bethany B. Moore;Kevin R. Flaherty;Kevin K. Brown.
American Journal of Respiratory and Critical Care Medicine (2007)

1131 Citations

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Ganesh Raghu;Martine Remy-Jardin;Jeffrey L. Myers;Luca Richeldi.
American Journal of Respiratory and Critical Care Medicine (2018)

1126 Citations

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

A U Wells;N Hirani.
Thorax (2008)

914 Citations

Interstitial lung disease in systemic sclerosis: a simple staging system.

Nicole S. L. Goh;Sujal R. Desai;Srihari Veeraraghavan;David M. Hansell.
American Journal of Respiratory and Critical Care Medicine (2008)

898 Citations

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline

Ganesh Raghu;Bram Rochwerg;Yuan Zhang;Carlos A. Cuello Garcia.
American Journal of Respiratory and Critical Care Medicine (2015)

873 Citations

The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society

Geoffrey D. Rubin;Christopher J. Ryerson;Linda B. Haramati;Nicola Sverzellati.
Chest (2020)

836 Citations

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

Rachel K Hoyles;Ross W Ellis;Jessica Wellsbury;Belinda Lees.
Arthritis & Rheumatism (2006)

814 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Athol U. Wells

Toby M. Maher

Toby M. Maher

University of Southern California

Publications: 205

Vincent Cottin

Vincent Cottin

Claude Bernard University Lyon 1

Publications: 186

Ganesh Raghu

Ganesh Raghu

University of Washington

Publications: 172

Luca Richeldi

Luca Richeldi

Catholic University of the Sacred Heart

Publications: 170

Kevin K. Brown

Kevin K. Brown

National Jewish Health

Publications: 154

Harold R. Collard

Harold R. Collard

University of California, San Francisco

Publications: 153

Fernando J. Martinez

Fernando J. Martinez

Cornell University

Publications: 132

Christopher P. Denton

Christopher P. Denton

University College London

Publications: 130

Jay H. Ryu

Jay H. Ryu

Mayo Clinic

Publications: 120

David A. Lynch

David A. Lynch

Children's Hospital of Philadelphia

Publications: 119

Kevin R. Flaherty

Kevin R. Flaherty

University of Michigan–Ann Arbor

Publications: 114

Thomas V. Colby

Thomas V. Colby

Mayo Clinic

Publications: 112

Dominique Valeyre

Dominique Valeyre

Université Paris Cité

Publications: 106

Demosthenes Bouros

Demosthenes Bouros

National and Kapodistrian University of Athens

Publications: 105

Naftali Kaminski

Naftali Kaminski

Yale University

Publications: 101

Takashi Ogura

Takashi Ogura

University of Hyogo

Publications: 98

Something went wrong. Please try again later.